Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
P Michael GrossmanSyed S AliHerbert D AronowMichael BorosTimothy J NypaverTheodore L SchreiberYeo Jung ParkPeter K HenkeHitinder S GurmPublished in: Journal of interventional cardiology (2017)
CIN is not an uncommon complication associated with PVI, can be reliably predicted from pre-procedural variables, including a contrast dose of greater than three times the CCC and is strongly associated with the risk of in-hospital death, MI, stroke, transfusion, and increased hospital length of stay.
Keyphrases
- risk factors
- patients undergoing
- magnetic resonance
- healthcare
- randomized controlled trial
- acute care
- atrial fibrillation
- adverse drug
- contrast enhanced
- high glucose
- diabetic rats
- cardiac surgery
- magnetic resonance imaging
- emergency department
- drug induced
- oxidative stress
- acute kidney injury
- metabolic syndrome
- weight loss
- brain injury
- insulin resistance
- cerebral ischemia
- electronic health record